Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acylated piperidine derivatives as melanocortin-4 receptor agonists

Acylated piperidine derivatives as melanocortin-4 receptor agonists

US Patent 7012084 · Granted Mar 14, 2006

Estimated economic value: $123,209,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long-acting co-agonists of the glucagon and GLP-1 receptors2022
Substituted carbapenems for the treatment of bacterial infections2021
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists2021
Insulin dimer-incretin conjugates2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment o2021
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,2021
Insulin receptor partial agonists2020
Long-acting co-agonists of the glucagon and GLP-1 receptors2020
Insulin receptor partial agonists2020
Antidiabetic tricyclic compounds2019
Tricyclic compounds as inhibitors of mutant IDH enzymes2019
Tricyclic compounds as inhibitors of mutant IDH enzymes2019